Real-time Estimate
Cboe Europe
04:07:08 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
286.9
CHF
|
-0.52%
|
|
+1.52%
|
+4.70%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
11,231
|
15,781
|
24,153
|
16,147
|
15,568
|
17,192
|
-
|
-
|
Enterprise Value (EV)
1 |
11,894
|
15,864
|
25,161
|
17,643
|
16,928
|
18,483
|
18,363
|
18,215
|
P/E ratio
|
23
x
|
27.2
x
|
37.4
x
|
25.1
x
|
26
x
|
27.2
x
|
23.6
x
|
21.2
x
|
Yield
|
1.66%
|
1.28%
|
1.14%
|
1.71%
|
1.65%
|
1.6%
|
1.76%
|
1.96%
|
Capitalization / Revenue
|
3.85
x
|
6.07
x
|
7.18
x
|
4.32
x
|
4.29
x
|
4.35
x
|
4.06
x
|
3.78
x
|
EV / Revenue
|
4.08
x
|
6.1
x
|
7.48
x
|
4.72
x
|
4.67
x
|
4.68
x
|
4.34
x
|
4.01
x
|
EV / EBITDA
|
16.7
x
|
18.8
x
|
25.9
x
|
17.9
x
|
18.5
x
|
17.7
x
|
16.1
x
|
14.4
x
|
EV / FCF
|
21.1
x
|
23.5
x
|
30.2
x
|
28
x
|
27.1
x
|
30
x
|
22.9
x
|
20.4
x
|
FCF Yield
|
4.74%
|
4.26%
|
3.32%
|
3.57%
|
3.69%
|
3.33%
|
4.37%
|
4.9%
|
Price to Book
|
5.41
x
|
5.74
x
|
9.82
x
|
7.34
x
|
6.32
x
|
6.7
x
|
6.02
x
|
5.63
x
|
Nbr of stocks (in thousands)
|
64,398
|
63,024
|
62,313
|
60,116
|
59,626
|
59,613
|
-
|
-
|
Reference price
2 |
174.4
|
250.4
|
387.6
|
268.6
|
261.1
|
288.4
|
288.4
|
288.4
|
Announcement Date
|
5/19/20
|
5/18/21
|
5/17/22
|
5/16/23
|
5/13/24
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
2,917
|
2,602
|
3,364
|
3,738
|
3,627
|
3,953
|
4,235
|
4,543
|
EBITDA
1 |
710.1
|
842.2
|
971.1
|
986.4
|
916.1
|
1,044
|
1,144
|
1,265
|
EBIT
1 |
510
|
619.5
|
760
|
746.7
|
669.9
|
806.2
|
899.3
|
994.9
|
Operating Margin
|
17.48%
|
23.81%
|
22.59%
|
19.97%
|
18.47%
|
20.4%
|
21.23%
|
21.9%
|
Earnings before Tax (EBT)
1 |
502.4
|
600.4
|
728.2
|
715.6
|
647.3
|
777.6
|
886.4
|
977
|
Net income
1 |
483.2
|
581
|
649
|
647.5
|
601
|
624.9
|
705.5
|
772.2
|
Net margin
|
16.56%
|
22.33%
|
19.29%
|
17.32%
|
16.57%
|
15.81%
|
16.66%
|
17%
|
EPS
2 |
7.570
|
9.190
|
10.35
|
10.72
|
10.05
|
10.61
|
12.21
|
13.63
|
Free Cash Flow
1 |
563.7
|
675.2
|
834.5
|
629.6
|
624.7
|
615.2
|
803.3
|
893.2
|
FCF margin
|
19.32%
|
25.95%
|
24.81%
|
16.84%
|
17.22%
|
15.56%
|
18.97%
|
19.66%
|
FCF Conversion (EBITDA)
|
79.38%
|
80.17%
|
85.93%
|
63.83%
|
68.19%
|
58.95%
|
70.24%
|
70.61%
|
FCF Conversion (Net income)
|
116.66%
|
116.21%
|
128.58%
|
97.24%
|
103.94%
|
98.45%
|
113.86%
|
115.66%
|
Dividend per Share
2 |
2.900
|
3.200
|
4.400
|
4.600
|
4.300
|
4.620
|
5.088
|
5.660
|
Announcement Date
|
5/19/20
|
5/18/21
|
5/17/22
|
5/16/23
|
5/13/24
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
1,491
|
1,070
|
1,532
|
1,604
|
1,760
|
1,847
|
1,892
|
1,753
|
1,874
|
EBITDA
|
368.7
|
327.7
|
514.5
|
477
|
494.1
|
482.8
|
-
|
-
|
-
|
EBIT
1 |
268.8
|
230
|
389.5
|
372.2
|
387.8
|
363.8
|
382.9
|
350
|
319.9
|
Operating Margin
|
18.03%
|
21.5%
|
25.42%
|
23.21%
|
22.03%
|
19.7%
|
20.24%
|
19.97%
|
17.07%
|
Earnings before Tax (EBT)
1 |
266.4
|
219.8
|
-
|
353
|
-
|
350.5
|
365.1
|
293.7
|
353.6
|
Net income
1 |
127.8
|
204.1
|
376.9
|
294.8
|
354.2
|
291.9
|
355.6
|
249.6
|
351.4
|
Net margin
|
8.57%
|
19.08%
|
24.6%
|
18.38%
|
20.12%
|
15.81%
|
18.8%
|
14.24%
|
18.75%
|
EPS
2 |
2.050
|
3.230
|
5.960
|
4.660
|
5.690
|
-
|
5.940
|
4.110
|
5.940
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/19/20
|
11/16/20
|
5/18/21
|
11/15/21
|
5/17/22
|
11/14/22
|
5/16/23
|
11/21/23
|
5/13/24
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
663
|
83.3
|
1,008
|
1,496
|
1,360
|
1,291
|
1,171
|
1,022
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.9337
x
|
0.0989
x
|
1.038
x
|
1.517
x
|
1.484
x
|
1.237
x
|
1.024
x
|
0.8081
x
|
Free Cash Flow
1 |
564
|
675
|
835
|
630
|
625
|
615
|
803
|
893
|
ROE (net income / shareholders' equity)
|
22.1%
|
24.4%
|
25.2%
|
29.1%
|
25.7%
|
25.9%
|
26.5%
|
26.2%
|
ROA (Net income/ Total Assets)
|
11%
|
11.2%
|
11.3%
|
12.1%
|
10.6%
|
11.9%
|
13%
|
13.3%
|
Assets
1 |
4,389
|
5,206
|
5,757
|
5,357
|
5,667
|
5,265
|
5,438
|
5,795
|
Book Value Per Share
2 |
32.20
|
43.60
|
39.50
|
36.60
|
41.30
|
43.10
|
47.90
|
51.20
|
Cash Flow per Share
2 |
13.20
|
12.10
|
15.00
|
13.00
|
12.60
|
13.50
|
15.70
|
17.20
|
Capex
1 |
129
|
89.2
|
107
|
154
|
129
|
147
|
156
|
162
|
Capex / Sales
|
4.42%
|
3.43%
|
3.17%
|
4.13%
|
3.55%
|
3.73%
|
3.68%
|
3.58%
|
Announcement Date
|
5/19/20
|
5/18/21
|
5/17/22
|
5/16/23
|
5/13/24
|
-
|
-
|
-
|
Last Close Price
288.4
CHF Average target price
280.9
CHF Spread / Average Target -2.61% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.10% | 19.18B | | +11.18% | 14.32B | | +12.84% | 10.53B | | +42.34% | 1.97B | | -3.83% | 1.63B | | +9.55% | 1.34B | | +3.95% | 542M | | 0.00% | 407M | | +57.45% | 182M | | +20.04% | 95.85M |
Medical Prosthetics
|